World Investment Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
5,187
-1
-0% -$207 0.02% 655
2026
Q1
$1.16M Buy
5,188
+307
+6% +$76.5K 0.02% 655
2025
Q4
$1.18M Buy
4,881
+1,319
+37% +$337K 0.02% 634
2025
Q3
$975K Sell
3,562
-69
-2% -$18.8K 0.02% 574
2025
Q2
$937K Buy
3,631
+131
+4% +$31.2K 0.02% 537
2025
Q1
$783K Buy
3,500
+169
+5% +$39.5K 0.02% 566
2024
Q4
$762K Buy
3,331
+1,115
+50% +$268K 0.02% 544
2024
Q3
$541K Buy
+2,216
New +$495K 0.02% 581

Other funds holding RMD

World Investment Advisors's RMD Position: Q2 2026 in Review

World Investment Advisors reduced its ResMed (RMD) stake by 0.02% in Q2 2026, selling an estimated $207 and leaving 5,187 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #655.

World Investment Advisors first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.18M in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • World Investment Advisors held 5,187 shares of ResMed worth $1.16M as of Q2 2026.
  • World Investment Advisors sold 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up 0.02% of World Investment Advisors's portfolio in Q2 2026, its #655 holding.
  • World Investment Advisors first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
  • World Investment Advisors's ResMed position peaked at $1.18M in Q4 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.